We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Urgent Care Centers May Overprescribe Antibiotics

By HospiMedica International staff writers
Posted on 10 Aug 2018
A new study suggests that unnecessary antibiotic prescribing for patients with common colds and respiratory illnesses is far more prevalent in urgent care centers and retail clinics.

Researchers at the U.S. More...
Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA), the University of Utah (Salt Lake City, USA), and Pew Charitable Trusts (Washington, DC, USA) conducted a retrospective cohort study of the 2014 Truven Health Analytics MarketScan commercial claims and encounters database, in order to compare antibiotic prescribing in retail clinics, urgent care centers, emergency departments (EDs), and traditional ambulatory care settings in the United States.

The results revealed that antibiotic prescriptions were linked to 39% of 2.7 million urgent care center visits, 36.4% of 58,206 retail clinic visits, 13.8% of 4.8 million ED visits, and 7.1 % of 148.5 million traditional ambulatory care settings. Respiratory diagnoses not suitable for antibiotics accounted for 17% of retail clinic visits, 16% of urgent care center visits, 6% of medical office visits, and 5% of ED visits. Antibiotic prescribing for inappropriate respiratory diagnoses was highest in urgent care centers (47%), followed by EDs (24.6%), medical offices (17%), and retail clinics (14.4%). The study was published on July 16, 2018, in JAMA Internal Medicine.

“Taking an antibiotic when it is not needed provides no benefit and could be harmful. Needless use of antibiotics can increase patients’ risk of getting antibiotic-resistant infections, or superbugs that are harder to treat,” said senior author Katherine Fleming-Dutra, MD, deputy director of the office of antibiotic stewardship at the CDC. “Other risks include allergic reactions, diarrhea, and the potential for harmful bacteria to flourish in the gut and cause infections in the future.”

Approximately two million people fall sick due to antibiotic-resistant infections every year, resulting in 23,000 deaths annually in the United States alone. Major drivers of resistance include self-medication, noncompliance, misinformation, and advertising pressures, combined with ignorance, lack of education, and lack of access to healthcare. The problem is complicated by economic and social barriers to rational use of drugs, for example in hospitals, where up to 50% of antibiotic use is inappropriate.

Related Links:
U.S. Centers for Disease Control and Prevention
University of Utah
Pew Charitable Trusts

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.